🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In recognition of #MDSWorldAwarenessDay, we ask that you retweet this post to bring awareness to Myelodysplastic Syndromes—a rare blood cancer. Honor someone specific, tag a loved one, or share just because. Each and every share makes a difference! mds-foundation.org

A great ressource coming out of Gustave Roussy Prism Center congrats ypradat and team!

What an outstanding Phd defense! Congratulations Dr. Sirenko and mentor Elli Papaemmanuil, PhD. Maria Sirenko you were fabulous so so proud of you!

Groundbreaking study on the promotion of lung cancer by air pollution in never smokers. Congrats Will Hill Emilia Lim Clare Weeden and all involved. Climate health is human health. Act now 🌍

You can now access the IPSS-M through web, android and apple app store! Web: mds-foundation.org/mds-iwg-pm/ iOS: apps.apple.com/gb/app/ipss-m-… Android: play.google.com/store/apps/det…

Proud to share our manuscript on clonal evolution during metastatic spread in high-risk neuroblastoma (HR-NB). A collaboration between Elli Papaemmanuil, PhD and Nai-Kong Cheung Labs in Memorial Sloan Kettering Cancer Center. nature.com/articles/s4158… See the thread below.

High-risk neuroblastoma (HR-NB) is a pediatric cancer characterized by overt metastatic disease at diagnosis, on-treatment progression and dismal outcomes. Our study, led by Gunes Gundem published in Nature Genetics today go.nature.com/3LSfVNX #CheungLab #MSKKids Memorial Sloan Kettering Cancer Center

🧬 Clonal Interception | Un programme scientifique précurseur pour anticiper le risque de #leucémie induite par de précédents traitements anticancéreux. Décryptage avec le Dr Jean-Baptiste Micol, hématologue à Gustave Roussy et porteur du projet 👇

Many congratulations to Chris Bailey for a stellar Phd defense yesterday 🥳! Chris is a dedicated hematologist, top notch bioinformatician, ecDNA world expert, cancer genomic gourou, and I am luck to call him my friend 💫. Much more to come from Chris in the future 🚀!

Happy to share our Edito on Gustave Roussy CHIP Molecular Tumor Board « Clonal Hematopoiesis in Patients With Cancer: How Much Should We Care? » ascopubs.org/doi/10.1200/PO…

Our editorial in JCO Precision Oncology describing the #CHIP MTB Gustave Roussy and thoughts for the future. Multidisciplinary effort as always! Pleasure to work with Jean-Baptiste Micol and Aline Renneville

The IPSS-M is a prognosis calculator for MDS patients. It combines genomic profiling with hematologic and cytogenetic parameters. This tool is intended for health care professionals to support with clinical decision making. Find our IPSS here: bit.ly/46TU2aj

Very happy 🥳to join Gustave Roussy to lead a Computational Clinical Oncology group! The team will employ cancer genomics 🧬and stats 🎯to improve precision diagnostics, stratification & early detection. Special heme🩸focus #tMN #CHIP. More soon for job offers!

Amazing work Charlotte Brierley and team!

Congratulations ypradat 🥳! Looking forward to working with you over the coming years! ypradat and I first met while training in Elli Papaemmanuil, PhD and our scientific adventure continues 🚀 Gustave Roussy Prism Center

Helping put together⭐️Embracing #cancer complexity: Hallmarks of systemic disease⭐️in Cell was a unique experience! Honored to participate in mapping out the complexities of cancer as a systemic disease🎯.🙏Charles Swanton and all coauthors really for this endeavour!

A pleasure (and fun!) to work w/ Maria Sirenko as she led this detective work 🕵️‍♀️on UBA1 mut in #MDSsm. Team work as always @MariaCreignou #IWG MDS Foundation with the most supportive mentor Elli Papaemmanuil, PhD. Cant wait to see Maria's future work w/ Iannis Aifantis 🚀 Thread 👇👇